GlaxoSmithKline PLC (GSK)
31 Jul 2014
|Market Cap (Mil.):||$117,072.20|
|Shares Outstanding (Mil.):||2,424.46|
LONDON - GlaxoSmithKline's fat dividend is under strain but Britain's biggest drugmaker is likely to scrape by without cutting payouts as it seeks to compensate investors during a bumpy reshaping of the company.
* GSK seen avoiding cut but dividend may flatline - analysts
SHANGHAI - The public trial of a foreign couple linked to GlaxoSmithKline Plc (GSK) is set for Aug. 8, a Shanghai court said on Tuesday.
SHANGHAI, July 29 - The public trial of a foreign couple linked to GlaxoSmithKline Plc (GSK) is set for Aug. 8, a Shanghai court said on Tuesday.
LONDON, July 25 - British lenders who focus on the domestic market outperformed a slightly negative FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic growth data.
LONDON, July 25 - British lenders who focus on the domestic market outpaced a flat FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic output data.
LONDON - GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.
LONDON - GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.
* Mosquito-borne malaria kills over 600,000 people a year
TEL AVIV - Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,700||-27.00|
|The Procter & Gamble Company (PG.N)||$77.32||-0.84|
|Johnson & Johnson (JNJ.N)||$100.09||-2.21|
|Pfizer Inc. (PFE.N)||$28.70||-0.56|
|Novartis AG (NOVN.VX)||CHF79.55||-0.80|
|Unilever N.V. (UNc.AS)||€30.82||-0.63|
|Unilever N.V. (UNIA.AS)||€31.39||-0.05|
|Unilever N.V. (UN_pa.AS)||--||--|
|Unilever N.V. (UN_p.AS)||€77.00||+0.10|
|Unilever N.V. (UN_pb.AS)||--||--|
Earnings vs. Estimates
Analyst Research Reports
Provider: Wright Reports
Provider: Thomson Reuters Stock Report
"The Economy Matters" Report for GSK: the economy's impact on GSK's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.